Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Huntington Ingalls Industries Inc (HII) vs Nuwellis Inc (NUWE) Price & Performance

Huntington Ingalls Industries IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Huntington Ingalls Industries Inc vs Nuwellis Inc — how do they compare? Huntington Ingalls Industries Inc trades at $326.2 (market cap $12.92B), while Nuwellis Inc trades at $1.4 (market cap $542.80K). The key difference: Huntington Ingalls Industries Inc is far larger — about 23802.5× Nuwellis Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

HIINUWE
Market Cap
$12.92B$542.80K
Sector
TechnologyTechnology
52-Week High
$453.73$220.50
52-Week Low
$265.40$1.42
Enterprise Value
$15.84B-$1.27M
Dividend Yield
1.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Huntington Ingalls Industries Inc

HII trades at $324.38, down 1.94% on the day, with a bullish technical signal supported by moving averages and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $5.27, exceeding expectations, and secured a $2.2 billion contract for surveillance capabilities (GlobeNewsWire, August 11, 2026). Valuation ratios include a P/E of 19.53 and P/S of 0.98, indicating reasonable pricing relative to earnings and sales.

Outlook remains positive due to contract wins and margin expansion, but risks include dependence on U.S. defense spending and competitive pressures. The consensus price target of $359.67 suggests upside potential, supported by 44% buy ratings from analysts.

Nuwellis Inc

NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.

Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Huntington Ingalls Industries Inc

Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.

Read more on HII

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE